Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR2 | P30874 | 9/20 | 0.50 |
| ▸ | SSTR4 | P31391 | 7/20 | 0.47 |
| ▸ | SSTR5 | P35346 | 7/20 | 0.47 |
| ▸ | SSTR1 | P30872 | 6/20 | 0.47 |
| ▸ | SSTR3 | P32745 | 6/20 | 0.47 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.41 |
| ▸ | ITGAV | P06756 | 1/20 | 0.41 |
| ▸ | NPBWR1 | P48145 | 6/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17404731 | 0.93 | SSTR2 (0.56) | SSTR2SSTR4SSTR5SSTR1SSTR3 | |
| SCHEMBL19542498 | 0.88 | SSTR2 (0.47) | SSTR2SSTR4SSTR5SSTR1SSTR3 | |
| SCHEMBL18712398 | 0.86 | SSTR2 (0.53) | SSTR2SSTR4SSTR5SSTR1SSTR3 | |
| SCHEMBL17404771 | 0.84 | SSTR2 (0.56) | SSTR2SSTR4SSTR5SSTR1SSTR3 | |
| SCHEMBL21892353 | 0.83 | SSTR2 (0.52) | SSTR2SSTR4SSTR5SSTR1SSTR3 | |
| SCHEMBL18712536 | 0.83 | SSTR2 (0.56) | SSTR2SSTR4SSTR5SSTR1SSTR3 | |
| SCHEMBL21099575 | 0.82 | SSTR2 (0.55) | SSTR2SSTR4SSTR5SSTR1SSTR3 | |
| SCHEMBL19308257 | 0.82 | SSTR2 (0.52) | SSTR2SSTR4SSTR5SSTR1SSTR3 | |
| SCHEMBL18712400 | 0.79 | SSTR2 (0.47) | SSTR2SSTR4SSTR5SSTR1SSTR3 | |
| SCHEMBL18712668 | 0.78 | SSTR2 (0.52) | SSTR2SSTR4SSTR5SSTR1SSTR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10322191-B2 | Targeted conjugates and particles and formulations thereof | TARVEDA THERAPEUTICS, INC. (US) | 2019-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10322191-B2 | Targeted conjugates and particles and formulations thereof | SSTR5, SSTR1, SSTR4 | SSTR2 4/4885SSTR4 3/4885SSTR5 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.